Using this approach, the authors were able to partially correct metabolic abnormalities of cybrid cells carrying mutations for MELAS (mitochondrial encephalopathy lactic acidosis and stroke) or MERRF (mitochondrial encephalopathy and ragged red fiber disease) [125]. Here, MT-TK is linked to Mitochondrial encephalopathy.